Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 197

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques

Open access
Amarenco, Pierre, Davis, Stephen, Jones, Elizabeth F., Cohen, Ariel A., Heiss, Wolf-Dieter, Kaste, Markku, Laouénan, Cédric, Young, Dennis, Macleod, Malcolm, Donnan, Geoffrey A., Bladin, Christopher F., Chambers, Brian R., Frayne, Judith, Hankey, Graeme J., Levi, Christopher R., Read, Stephen J., Ravaud, Philippe, Tatlisumak, Turgut, Soinne, Lauri, Laine, Mika, Syvänne, Mikko, Vikatmaa, Pirkka, Lepäntalo, Mauri, Mentré, France, Gosset, Simon, Churilov, Leonid, De Broucker, Thomas, Favrole, Pascal, Mawet, Jérôme, Mocquard, Yves, Obadia, Michael, Godefroy, Olivier, Hosseini, Hassan, Pico, Fernando, Garnier, Pierre, Malbec, Marcel, Pinel, Jean-François, Ille, Olivier, Vadamme, Xavier, Macian-Montoro, Francisco, Servan, Jérôme, Viallet, François, Rosolacci, Thierry, Lecoz, Patrick, Clavelou, Pierre, Detante, Olivier, Cho, Tae-Hee, Saudeau, Denis, Michel, Patrik, D’Ombrogio, Suzette, Serisier, David, Sturm, Jonathon, Kimber, Thomas, Marcus, Romesh, Schwartz, Ray, Helme, Rob, Blacker, David, Wood, Jonathan · 2014 · Stroke

Abstract

Background and Purpose—: Severe atherosclerosis in the aortic arch is associated with a high risk of recurrent vascular events, but the optimal antithrombotic strategy is unclear. Methods—: This prospective randomized controlled, open-labeled trial, with blinded end point evaluation (PROBE design) tested superiority of aspirin 75 to 150 mg/d plus clopidogrel 75 mg/d (A+C) over warfarin therapy (international normalized ratio 2–3) in patients with ischemic stroke, transient ischemic attack, or peripheral embolism with plaque in the thoracic aorta >4 mm and no other identified embolic source. The primary end point included cerebral infarction, myocardial infarction, peripheral embolism, vascular death, or intracranial hemorrhage. Follow-up visits occurred at 1 month and then every 4 months post randomization. Results—: The trial was stopped after 349 patients were randomized during a period of 8 years and 3 months. After a median follow-up of 3.4 years, the primary end point occurred in 7.6% (13/172) and 11.3% (20/177) of patients on A+C and on warfarin, respectively (log-rank, P =0.2). The adjusted hazard ratio was 0.76 (95% confidence interval, 0.36–1.61; P =0.5). Major hemorrhages including intracranial hemorrhages occurred in 4 and 6 patients in the A+C and warfarin groups, respectively. Vascular deaths occurred in 0 patients in A+C arm compared with 6 (3.4%) patients in the warfarin arm (log-rank, P =0.013). Time in therapeutic range (67% of the time for international normalized ratio 2–3) analysis by tertiles showed no significant differences across groups. Conclusions—: Because of lack of power, this trial was inconclusive and results should be taken as hypothesis generating. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00235248.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.113.004251

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 197

Metadata

Authors
Amarenco, P., Davis, S., Jones, E. F., Cohen, A. A., Heiss, W.-D., Kaste, M., Laouénan, C., Young, D., Macleod, M., Donnan, G. A., Bladin, C. F., Chambers, B. R., Frayne, J., Hankey, G. J., Levi, C. R., Read, S. J., Ravaud, P., Tatlisumak, T., Soinne, L., Laine, M., Syvänne, M., Vikatmaa, P., Lepäntalo, M., Mentré, F., Gosset, S., Churilov, L., De Broucker, T., Favrole, P., Mawet, J., Mocquard, Y., Obadia, M., Godefroy, O., Hosseini, H., Pico, F., Garnier, P., Malbec, M., Pinel, J.-F., Ille, O., Vadamme, X., Macian-Montoro, F., Servan, J., Viallet, F., Rosolacci, T., Lecoz, P., Clavelou, P., Detante, O., Cho, T.-H., Saudeau, D., Michel, P., D’Ombrogio, S., Serisier, D., Sturm, J., Kimber, T., Marcus, R., Schwartz, R., Helme, R., Blacker, D., & Wood, J.
Venue
Stroke
Published
2014-05
Volume
45
Issue
5
Pages
1248-1257
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2150362365
Cited by
197
References
10
FWCI
13.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques. https://app.cochat.ai/papers/10.1161/strokeaha.113.004251
The paper
Amarenco, P., Davis, S., Jones, E. F., Cohen, A. A., Heiss, W.-D., Kaste, M., Laouénan, C., Young, D., Macleod, M., Donnan, G. A., Bladin, C. F., Chambers, B. R., Frayne, J., Hankey, G. J., Levi, C. R., Read, S. J., Ravaud, P., Tatlisumak, T., Soinne, L., . . . Wood, J. (2014). Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques. Stroke. https://doi.org/10.1161/strokeaha.113.004251

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.